AAAAAA
Results:
1-7
|
Results: 7
Authors:
Gitlitz, BJ
Hoffman, DMJ
Moldawer, N
Belldegrun, A
Figlin, RA
Citation: Bj. Gitlitz et al., Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: An analysis of 124 consecutively treated patients, CANCER J, 7(2), 2001, pp. 112-120
Authors:
Zisman, A
Pantuck, AJ
Dorey, F
Said, JW
Shvarts, O
Quintana, D
Gitlitz, BJ
deKernion, JB
Figlin, RA
Belldegrun, AS
Citation: A. Zisman et al., Improved prognostication of renal cell carcinoma using an integrated staging system, J CL ONCOL, 19(6), 2001, pp. 1649-1657
Authors:
Zisman, A
Pantuck, AJ
Chao, D
Dorey, F
Said, JW
Gitlitz, BJ
de Kernion, JB
Figlin, RA
Belldegrun, AS
Citation: A. Zisman et al., Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. Better correlates with clinicaloutcome, J UROL, 166(1), 2001, pp. 54-58
Authors:
Hinkel, A
Tso, CL
Gitlitz, BJ
Neagos, N
Schmid, I
Paik, SH
deKernion, J
Figlin, R
Belldegrun, A
Citation: A. Hinkel et al., Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma, J IMMUNOTH, 23(1), 2000, pp. 83-93
Authors:
Hoffman, DMJ
Gitlitz, BJ
Belldegrun, A
Figlin, RA
Citation: Dmj. Hoffman et al., Adoptive cellular therapy, SEMIN ONCOL, 27(2), 2000, pp. 221-233
Authors:
Roth, MD
Gitlitz, BJ
Kiertscher, SM
Park, AN
Mendenhall, M
Moldawer, N
Figlin, RA
Citation: Md. Roth et al., Granulocyte macrophage colony-stimulating factor and interleukin 4 enhancethe number and antigen-presenting activity of circulating CD14(+) and CD83(+) cells in cancer patients, CANCER RES, 60(7), 2000, pp. 1934-1941
Authors:
Gitlitz, BJ
Belldegrun, AS
Figlin, RA
Citation: Bj. Gitlitz et al., Adoptive immunotherapy in renal cell carcinoma, CUR CLIN ON, 4, 2000, pp. 359-379
Risultati:
1-7
|